HCA Healthcare (HCA) Shares Outstanding (Weighted Average) (2010 - 2026)

HCA Healthcare (HCA) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $223.6 million in Q1 2026.

• Shares Outstanding (Weighted Average) for Q1 2026 came in at $223.6 million, down 9.46% year-over-year; the trailing twelve-month figure through Mar 2026 was $223.6 million (down 9.46% YoY), and the FY2025 annual result was $236.4 million, down 8.58% from the prior year.
• Shares Outstanding (Weighted Average) eased to $223.6 million in Q1 2026 per HCA's latest filing, from $236.4 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $302.4 million in Q1 2022 and troughed at $223.6 million in Q1 2026.
• A 5-year average of $265.0 million and a median of $264.4 million in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Weighted Average) retreated 12.83% in 2022, then slipped 3.84% in 2024.
• A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $290.3 million in 2022, then decreased by 6.18% to $272.4 million in 2023, then declined by 5.07% to $258.6 million in 2024, then fell by 8.58% to $236.4 million in 2025, then dropped by 5.42% to $223.6 million in 2026.
• Business Quant data shows HCA's Shares Outstanding (Weighted Average) at $223.6 million in Q1 2026, $236.4 million in Q4 2025, and $239.6 million in Q3 2025.